PARA BIO FPO (ASX: PAR) Share Price and News

ASX stock of the day: Paradigm Biopharmaceuticals share price rockets 9% after clinical trials see chronic pain in osteoarthritis patients drop by 44%

Kate O'Brien | April 28, 2020 2:00pm

The Paradigm Biopharmaceuticals Limited (ASX: PAR) share price is up 9.03% today after the healthcare company reported strong results from its clinical studies. More »

Why Afterpay, Baby Bunting, Paradigm, & Saracen shares are storming higher

James Mickleboro | March 24, 2020 11:36am

Afterpay Ltd (ASX:APT) and Paradigm Biopharmaceuticals Ltd (ASX:PAR) shares are two of four storming notably higher on Tuesday... More »

Paradigm share price rockets 17% higher on Zilosul update

James Mickleboro | March 24, 2020 10:07am

The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price is rocketing higher on Tuesday. Here's why its shares are up 17% this morning... More »

Why this ASX healthcare share has risen over 200% in the past year

Phil Harpur | March 13, 2020 9:56am

The Opthea Ltd (ASX: OPT) share price is up more than 200% in the past year. Here we take a closer look at what... More »

Why these All Ords shares have doubled in value in 12 months

James Mickleboro | March 6, 2020 8:16am

Megaport Ltd (ASX:MP1) and these ASX shares have doubled in value over the last 12 months. Here's why they are flying high... More »

Why Paradigm Biopharmaceuticals is one to watch in 2020

Jordan Liu | February 25, 2020 12:10pm

Paradigm Biopharmaceuticals Ltd (ASX: PAR) shares have tripled in value over the last 12 months. Here's a closer look at the company and why... More »

These 3 ASX healthcare shares could make you rich

Rhys Brock | February 21, 2020 10:29am

Here are 3 ASX healthcare shares looking to carve out their own niches – and in doing so, might even grow into tomorrow’s CSL... More »

Paradigm share price tumbles lower on FDA update

James Mickleboro | February 21, 2020 10:10am

The Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price is shooting higher on Friday after providing a positive update on its U.S. activities... More »

Paradigm Biopharmaceuticals shares lower despite US update

Kate O'Brien | February 18, 2020 4:01pm

The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price was down 5.1% today despite announcing it has treated its first patient with Zilosul in the... More »

Leading brokers name 3 ASX shares to sell today

James Mickleboro | February 18, 2020 3:07pm

Leading brokers have named Bendigo and Adelaide Bank Ltd (ASX:BEN) and these ASX shares as sells... More »

Paradigm Biopharmaceuticals shares have skyrocketed. Should you invest?

Rhys Brock | February 3, 2020 9:53am

The share price of ASX biotech company Paradigm Biopharmaceuticals Ltd (ASX: PAR) has surged over 250% in the last 12 months. Here’s why you... More »

Why this growing ASX healthcare company should be on everyone’s watch lists

Rhys Brock | January 29, 2020 9:21am

Shares of emerging biotechnology company Opthea Ltd (ASX: OPT) have more than quadrupled in price since August last year. More »

Why these ASX shares just raced to 52-week highs or better

James Mickleboro | January 28, 2020 6:36am

Paradigm Biopharmaceuticals Ltd (ASX:PAR) and these ASX shares have just raced to 52-week highs or better. Here's why... More »

I would buy Zip Co and these ASX mid cap stars in February

James Mickleboro | January 24, 2020 3:14pm

I think Zip Co Ltd (ASX:Z1P) and these mid cap ASX shares could be great options for investors in February... More »